If you've had Crohn's disease for at least three months you may be able to participate in one of these studies at Providence Swedish. Learn more.
Crohn’s disease causes inflammation and affects the digestive tract. There are treatments for Crohn's but no cure. Providence Swedish is the site for two investigational studies of medicines that can help people diagnosed with Crohn’s disease. You may be eligible to participate if you meet certain criertia. Call our lead clinical research coordinator at 206-745-9845, or email dhiresearch@providence.org to learn more about participating.
Ares is being tested to see if it may control the inflammation and fibrosis caused by Crohn's and help resolve or improve its symptoms.
You may qualify to take part in this study if you have had Crohn’s for at least 3 months and currently have moderately to severely active Crohn’s disease, and have had difficulty responding to other treatment.
The VICTRIVA study is evaluating an investigational therapy that combines two medications, vedolizumab and Upadacitinib.
The VICTRIVA study is evaluating an investigational therapy that combines two medications (vedolizumab and Upadacitinib). You may qualify to take part in this study if you have had Crohn’s for at least 3 months and your Crohn’s is at least moderately active.
About Providence Swedish
Providence Swedish has served the Puget Sound region since the first Providence hospital opened in Seattle in 1877 and the first Swedish hospital opened in 1910. The two organizations affiliated in 2012 and today comprise the largest health care delivery system in Western Washington, with 22,000 caregivers, eight hospitals and 244 clinics throughout Western Washington – from Everett to Centralia. A not-for-profit family of organizations, Providence Swedish provides more than $545 million in community benefit in the Puget Sound region each year. The health system offers a comprehensive range of services and specialty and subspecialty care in a number of clinical areas, including cancer, cardiovascular health, neurosciences, orthopedics, digestive health and women’s and children’s care.
